Risperdal and Tamiflu Hidden Data

Tamiflu: A new review of the influenza drug oseltamivir (Tamiflu) has raised questions about both the efficacy of the medication and the commitment of its maker to supply enough data for claims about the drug to be evaluated by independent experts.

We looked into our own thoughts on Tamiflu. We talked about it here on our very second post on the CCS.

Risperdal: Johnson & Johnson officials hid three studies showing some patients using Risperdal developed diabetes while claiming the antipsychotic drug didn’t cause the disease, a witness testified.

I'm starting to think there may be some systemic dishonesty in the Cargo Cults.

Type I error and Type II error are precise technical terms used in statistics to describe particular flaws in a testing process, where a null hypothesis that should have been accepted was rejected (Type I error) or where that hypothesis should have been rejected, but was accepted (Type II error).

Clearly Roche and J&J did not make an error. The came to the right conclusions and decided that no one should be allowed to come to the same conclusions. Johnson and Johnson was hit with a $158 million fine this week. Tamiflu and Roche seem to be getting away with their sins against science.

They made billions, for those who don't follow this Cargo Cults. They did not make an error. In the Cargo Cults, Risperdal and Tamiflu are success stories. And they created a lot of jobs in their legal departments.